Literature DB >> 7717095

The advent of selective monoamine oxidase A inhibitor antidepressants devoid of the cheese reaction.

M B Youdim1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7717095     DOI： 10.1111/j.1600-0447.1995.tb05917.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN： 0065-1591


× No keyword cloud information.
  4 in total

Review 1.  Predicting monoamine oxidase inhibitory activity through ligand-based models.

Authors:  Santiago Vilar; Giulio Ferino; Elias Quezada; Lourdes Santana; Carol Friedman
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

2.  A review of the literature on the selegiline transdermal system: an effective and well-tolerated monoamine oxidase inhibitor for the treatment of depression.

Authors:  Larry Culpepper; Lawrence J Kovalick
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

Review 3.  Monoamine Oxidase (MAO) as a Potential Target for Anticancer Drug Design and Development.

Authors:  Reem Aljanabi; Lina Alsous; Dima A Sabbah; Halise Inci Gul; Mustafa Gul; Sanaa K Bardaweel
Journal:  Molecules       Date:  2021-10-04       Impact factor: 4.411

4.  Rasagiline in treatment of Parkinson's disease.

Authors:  Lakshmi Nayak; Claire Henchcliffe
Journal:  Neuropsychiatr Dis Treat       Date:  2008-02       Impact factor: 2.570
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.